Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP

Fig. 2

Assessment of respiratory function and impedance in patients with mild to moderate asthma. Changes in respiratory function by spirometry (A) and changes in respiratory resistance by FOT (B) at 3 months and 1 year after dupilumab administration are shown. Pre and 3 month: n = 50, 1 year: n = 18. Each panel shown represents the mean ± SD. *p < 0.05, **p < 0.01 by student’s t test

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us